COMMUNIQUÉS West-GlobeNewswire

-
Alpha Tau Treats First Patient with Recurrent Lung Cancer
10/10/2024 -
Aprea Therapeutics Announces Presentations at EORTC-NCI-AACR International Conference on Molecular Targets and Therapeutics
10/10/2024 -
Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program
10/10/2024 -
Palisade Bio Cleared by Health Canada to Commence Phase 1 Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis (UC)
10/10/2024 -
SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation
10/10/2024 -
Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site
10/10/2024 -
MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer
10/10/2024 -
Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement
10/10/2024 -
Immutep to Participate in the 2024 Maxim Healthcare Virtual Summit
10/10/2024 -
Construction of JinMed's New Facility Begins in Chuzhou, China
10/10/2024 -
Bionano Announces Preliminary 3Q 2024 Revenues and Cash
10/10/2024 -
Information on the total number of voting rights and shares
09/10/2024 -
Informations sur le nombre total de droits de vote et d'actions
09/10/2024 -
Kairos Pharma to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
09/10/2024 -
Publication relating to transparency notifications
09/10/2024 -
Publication relative à des notifications de transparence
09/10/2024 -
Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024
09/10/2024 -
ORIC® Pharmaceuticals Announces Presentation at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
09/10/2024 -
Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit
09/10/2024
Pages